Contained
use of GMOs and pathogens In Belgium, the legislation concerning the contained use of genetically modified micro-organisms (GMMs) is implemented and enforced at the regional level. That means that three texts of transposition (one per Region) have to be published. Since 1997, a juridical tool named "Co-operation agreement" has been set up to ensure that the transposition and practical implementation of relevant EU Directives are done in a harmonised way between the three Regions at the administrative and scientific levels. Althought some of the new provisions contained in Directive 98/81/EC were already covered by the regional regulatory frameworks implementing Directive 90/219/CEE, it has been necessary to revise these regional decrees to fully implement the new Directive 98/81/CE. The ambition of the regional authorities was to perform such a revision not only on the basis of the new provisions of the Directive, but also considering other aspects such as:
In February 2000, an ad hoc working group gathering together the representatives of the three Regions (including lawyers) under the coordination of the SBB (Biosafety and Biotechnology Unit) was officially set up by the "Interministerial Coordination Committee for the International Environmental Policy" (CCPIE-CCIM). This Biosafety ad hoc Working Group held height meetings between February and November 2000. In the same time, a group of lawyers met 10 times. As a result of these 10 months of discussions, the Working Group published a report to the attention of the political authorities, listing the points of harmonisation on the basis of which the Regions agreed to finalise the implementation of Directive 98/81/EC. After several months of further discussions at the political level, the regional Decrees implementing the Directive 98/81/CE have come into force respectively in November 2001 in the Brussels Region, in July 2002 in the Walloon Region, and in February 2004 in the Flemish Region.
|